Applied Biotechnology Institute Inc.
San Luis Obispo, CA
- UEI
- XNMLFC55AWN3
- CAGE
- 4A1R9
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 1 Grand Ave Bldg 83-1D, San Luis Obispo, CA 93405, USA
- Website
- appliedbiotech.org
- Employees
- 1-10
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Production of low-cost heat stable forms of adalimumab in maize for treatment of inflammatory bowel disease. -… | National Institute of Allergy and Infectious Diseases | $299,936 | |
| Low-cost production of a vaccine for lyme disease in maize - project summary/abstract in keeping with the NIH's stated… | National Institute of Allergy and Infectious Diseases | $1,469,905 | |
| Orally-delivered fish vaccines | Institute of Food Production and Sustainability | $99,935 | |
| Production of a candidate vaccine for avian coccidiosis in maize | Institute of Food Production and Sustainability | $99,523 | |
| Production of stabilized trimeric HIV ENV protein in maize | National Institute of Allergy and Infectious Diseases | $149,928 |
About Applied Biotechnology Institute Inc.
Applied Biotechnology Institute Inc. is a biotechnology company with an innovative protein production platform that uses a proprietary animal-free system to develop products with health and environmental benefits. It is a for-profit, veteran-owned Subchapter S Corporation registered in SAM.gov.
Over the past few years, Applied Biotechnology Institute Inc. has received several federal grants for its work on developing alternative vaccine delivery methods and production systems. In 2021, the National Institute of Allergy and Infectious Diseases awarded the company a $1.47 million grant under the Allergy and Infectious Diseases Research program to develop a low-cost vaccine for Lyme disease delivered through genetically modified maize. The project aims to produce the OspA antigen in maize plants and administer it orally to mice through maize flour to evaluate the immune response and protective efficacy against Borrelia burgdorferi, the bacterium that causes Lyme disease. Immuno Technologies Inc. is a sub-awardee on this project, conducting mouse feeding studies and tick challenge experiments. In 2019, Applied Biotechnology Institute Inc. received two smaller grants from the USDA's National Institute of Food and Agriculture – one for $99,935 to develop orally-delivered fish vaccines and another for $99,523 to produce a candidate vaccine for avian coccidiosis in maize. These projects demonstrate the company's focus on developing plant-based vaccine production and oral delivery systems across various animal and human applications.
Quick answers
What is Applied Biotechnology Institute Inc.'s UEI?
Applied Biotechnology Institute Inc.'s Unique Entity ID (UEI) in SAM.gov is XNMLFC55AWN3.
What is Applied Biotechnology Institute Inc.'s CAGE code?
Applied Biotechnology Institute Inc.'s CAGE code is 4A1R9.
What is Applied Biotechnology Institute Inc.'s primary NAICS code?
Applied Biotechnology Institute Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Applied Biotechnology Institute Inc. located?
Applied Biotechnology Institute Inc.'s physical address in SAM.gov is 1 Grand Ave Bldg 83-1D, San Luis Obispo, CA 93405, USA.
Is Applied Biotechnology Institute Inc. registered in SAM.gov?
Yes. Applied Biotechnology Institute Inc.'s SAM.gov registration is active through July 9, 2027.
What is Applied Biotechnology Institute Inc.'s most recent federal award?
Applied Biotechnology Institute Inc.'s most recent federal grant award is Production of low-cost heat stable forms of adalimumab in maize for treatment of inflammatory bowel disease. -… (R43AI186801), from National Institute of Allergy and Infectious Diseases, on August 14, 2026.
On GovTribe
See Applied Biotechnology Institute Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors